Leap Therapeutics Profit Margin

As of the most recent data (June 2026), LPTX shows a profit margin of 17655.5%. That is above the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 13.89%. Leap Therapeutics is at 17655.5%, which is higher that average. That is roughly 127008.0% above the sector mean. Use the comparison chart on this page to see how LPTX stacks up against individual peers as well.

Check the historical chart to see whether LPTX's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Leap Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Leap Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 17655.5%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 13.89%, while LPTX is at 17655.5%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.